Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study

INTRODUCTION: Seasonal (inactivated) influenza vaccination is recommended for all individuals aged 65+ and in individuals under 65 who are at an increased risk of complications of influenza infection, for example, people with asthma. Live attenuated influenza vaccine (LAIV) was recommended for child...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Simpson, Colin R, Lone, Nazir I, Kavanagh, Kimberley, Robertson, Chris, McMenamin, Jim, von Wissmann, Beatrix, Vasileiou, Eleftheria, Butler, Chris, Ritchie, Lewis D, Gunson, Rory, Schwarze, Jürgen, Sheikh, Aziz
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2017
Matèries:
Health Services Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337698/
https://ncbi.nlm.nih.gov/pubmed/28246142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-014200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars